verified SJR 0,687 · Q2 • database Scopus / SJR & Web of Science indexed

Hong Kong · AME Publishing Company

workspace_premium Q2 — Oncology lock_open Open Access

Journal of Gastrointestinal Oncology

Journal of Gastrointestinal Oncology is a journal indexed in SJR in Oncology and Gastroenterology with an H index of 60. It has an SJR impact factor of 0,687 and it has a best quartile of Q2. It has an SJR impact factor of 0,687.

ISSN: 2078-6891

Publisher: AME Publishing Company

Category: Oncology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,687 Q2

H-index 60

Acceptance rate pie_chart

31%

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Open Access

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,687

H-index

Docs (year)

247

Docs 3y

854

Total refs

8364

Cites 3y

1760

Citable 3y

798

Cites/Doc 2y

1.88

Ref/Doc

33.86

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Artonin E sensitizes TRAIL-induced apoptosis by DR5 upregulation and cFLIP downregulation in TRAIL-refractory colorectal cancer LoVo cells

What to expect with major vascular reconstruction during Whipple procedures: a single institution experience and literature review

Curative treatment for metastatic colorectal cancer in the young population: is it worth it?

CT-based assessment of visceral adiposity and outcomes for esophageal adenocarcinoma

Cost-utility analysis of 5-fluorouracil and capecitabine for adjuvant treatment in locally advanced rectal cancer

Complete response to pembrolizumab in a patient with metastatic colon cancer with microsatellite instability and a history of Guillain-Barre syndrome

Comparison of tumor regression grading system in locally advanced esophageal squamous cell carcinoma after preoperative radio-chemotherapy to determine the most accurate system predicting prognosis

Comparison of perioperative chemotherapy with adjuvant chemoradiotherapy for resectable gastric cancer: findings from a population-based study

Combined dabrafenib and trametinib treatment in a case of chemotherapy-refractory extrahepatic BRAF V600E mutant cholangiocarcinoma: dramatic clinical and radiological response with a confusing synchronic new liver lesion

Clinical outcomes of endoscopic submucosal tunnel dissection compared with conventional endoscopic submucosal dissection for superficial esophageal cancer: a systematic review and meta-analysis

Clinical impact of underutilization of adjuvant therapy in node positive gastric adenocarcinoma

Clinical fate of T0N1 esophageal cancer: results from the National Cancer Database

SHOW MORE ARTICLES

Changing paradigm in pancreatic cancer: from adjuvant to neoadjuvant chemoradiation

A case of gastric small cell carcinoma with metastases to bone and liver

An unusual case of primary acinar cell carcinoma of the liver and its treatment

An unusual case of obstructive jaundice: ampullary Burkitt lymphoma

Ampullary and pancreatic adenocarcinoma - a comparative study

Aggressive mutation in a familial adenomatous polyposis syndrome family: when phenotype guides clinical surveillance

Advances in cholangiocarcinoma research: report from the third Cholangiocarcinoma Foundation Annual Conference

Advanced biliary tract cancer: clinical outcomes with ABC-02 regimen and analysis of prognostic factors in a tertiary care center in the United States

Adjuvant radiation provides survival benefit for resected pancreatic adenocarcinomas of the tail

Accuracy of nodal staging is influenced by sidedness in colon cancer

A rare case of primary rectal squamous cell carcinoma diagnosed by endoscopic ultrasound

A phase I trial of Proton stereotactic body radiation therapy for liver metastases

FAQs

Journal of Gastrointestinal Oncology has an SJR of 0,687 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Journal of Gastrointestinal Oncology is 31%.

Journal of Gastrointestinal Oncology

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Journal of Gastrointestinal Oncology?

What is the APC / publication cost?

What is the acceptance rate?